Won-Tae Cha
Net worth: 18 M $ as of 2026-08-30
Net worth: 18 M $ as of 2026-08-30
Won-Tae Cha currently works at Cha Biotech Co., Ltd., as Chief Executive Officer from 2026, Cha Medical & Bio Group, as Vice Chairman, and Stem Cell & Regenerative Medicine International, Inc., as Director.
Mr. Cha received his undergraduate degree from Duke University, Masters Business Admin degree from Massachusetts Institute of Technology, graduate degree from Yale University, and doctorate degree from Yonsei University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-08 | 3,110,518 ( 3.34% ) | 18 M $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| CHABIOTECH CO.,LTD. | Chief Executive Officer | 2026-03-03 |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cha Biotech Co., Ltd.
Cha Biotech Co., Ltd. Electronic ComponentsElectronic Technology Manufactures and designs optical, digital, and medical products and related cell therapy and biological products | Electronic Technology |
Stem Cell & Regenerative Medicine International, Inc.
Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Select your edition
All financial news and data tailored to specific country editions